Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 ,inter alia, to consider and approve Un-audited Financial Results for the ....
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Ltd has informed the exchanges that its Board of Directors will meet on Saturday, 2 August 2025. The main agenda items are: (1) to consider and approve the unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended 30 June 2025) along with the limited review report from statutory auditors, and (2) to evaluate and approve a proposal for raising funds through non-convertible debentures, bonds, or other debt securities, subject to regulatory approvals. The company's registered office will host the meeting. No financial figures have been disclosed at this stage.
This is a routine pre-results intimation, so no immediate impact on the stock. Investors should watch for the actual Q1 numbers on 2 August and watch for details on the proposed debt issuance, which could affect leverage and interest costs if approved.